Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,760
datasets available to search
ShareScore release 0.9.0
Dataset results
1,760 results for “phase 2”
A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer
ClinicalTrials.gov study NCT01357395. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase 2 Study of Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis
ClinicalTrials.gov study NCT05096364. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
ClinicalTrials.gov study NCT06566742. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer
ClinicalTrials.gov study NCT05184803. IPD Sharing: NO. Countries: 1. Publications: 0.
POWERPLAY Phase 2: Development and Evaluation in Male-dominated Workplaces
ClinicalTrials.gov study NCT03781453. IPD Sharing: NO. Countries: 1. Publications: 0.
Serplulimab for Patients With Non-small Cell Lung Cancer (NSCLC) With TPS ≥ 50%: a Prospective, Single-center, Single-arm Phase 2 Study.
ClinicalTrials.gov study NCT06195683. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia
ClinicalTrials.gov study NCT06797401. IPD Sharing: NO. Countries: 1. Publications: 0.
Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme
ClinicalTrials.gov study NCT01866449. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT06858735. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
ClinicalTrials.gov study NCT07388550. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase II Safety Study of 2 Dose Regimens of HepaStem in Patients With ACLF
ClinicalTrials.gov study NCT02946554. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke
ClinicalTrials.gov study NCT00499902. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118
ClinicalTrials.gov study NCT01670513. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
ClinicalTrials.gov study NCT05945823. IPD Sharing: NO. Countries: 4. Publications: 0.
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
ClinicalTrials.gov study NCT06659549. IPD Sharing: UNDECIDED. Countries: 8. Publications: 0.
A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials
ClinicalTrials.gov study NCT06736262. IPD Sharing: NO. Countries: 2. Publications: 0.
A Multicenter Phase 2 Single-arm Proof-of-concept Trial to Assess the Efficacy and Safety of Ustekinumab in Association With Prednisone for the Treatment of Non-infectious Severe Uveitis (NISU)
ClinicalTrials.gov study NCT03847272. IPD Sharing: Not stated. Countries: 1. Publications: 0.
OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye
ClinicalTrials.gov study NCT02468700. IPD Sharing: NO. Countries: 0. Publications: 0.
Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06318897. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction
ClinicalTrials.gov study NCT02277613. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.